Nitric oxide administration during and after multiple-valve heart surgery significantly reduced patients’ chances of developing acute and chronic kidney problems, according to a randomized trial published in the American Journal of Respiratory and Critical Care Medicine.
A deep-learning algorithm can automatically calculate left ventricular ejection fraction (LVEF) with less variability than cardiologists, according to a study presented June 25 at the American Society of Echocardiography’s annual scientific sessions.
Just a week after Baylor St. Luke’s Medical Center in Houston reopened its heart transplant program, CMS sent a letter to the hospital saying it will cut off funding for the program beginning Aug. 17.
DUBLIN — June 25, 2018 — Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it has received CE (Conformité Européenne) Mark for the MiniMed(TM) 670G hybrid closed loop system — the first and only system to automate and personalize the delivery of basal insulin 24 hours a day.
RIDGEFIELD, Conn. and INDIANAPOLIS, June 23, 2018 — Boehringer Ingelheim and Eli Lilly and Company (NYSE: LLY) today announced findings from two new analyses of the landmark EMPA-REG OUTCOME® trial, presented at the 78th American Diabetes Association (ADA) Scientific Sessions®.
The FDA announced on June 21 it has approved the Eversense Continuous Glucose Monitoring (CGM) system, the first fully implantable product of its kind. The device can be worn for up to 90 days, whereas most CGMs are replaced every week or two.
A multidisciplinary group of physicians, nurses, pharmacists and patients teamed up to provide guidelines on how many opioid painkillers should be prescribed following specific procedures.
Continuing cardiac resynchronization therapy (CRT) appeared to offer no benefit to patients who received a continuous flow left ventricular assist device (CF-LVAD), according to a multicenter study published in the Journal of the American Heart Association.
